Article

Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers

Journal of Clinical Oncology
DOI: 10.1200/JCO.23.02763
3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Radford, J. (2024, June 1). Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers. Journal of Clinical Oncology. Lippincott Williams and Wilkins. https://doi.org/10.1200/JCO.23.02763

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free